首页>
外国专利>
Pharmaceutical compositions and Methods comprising a combination of a selective oestrogen Receptor Modulator and an aromatase inhibitor
Pharmaceutical compositions and Methods comprising a combination of a selective oestrogen Receptor Modulator and an aromatase inhibitor
展开▼
机译：包含选择性雌激素受体调节剂和芳香酶抑制剂的组合的药物组合物和方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
1. Pharmaceutical ingredients and treatment methods, including providing a (-) - cis-6-phenyl-5 - [4 - (2-pirrolidin-1-il-etoxi) - phenyl] - 5, 6, 7, 8-tetrahydronaphenyl-2-ol or an acceptable salt or recipe, as well as an aromatic inhibitor to patients in need. In particular, this document deals with pharmaceutical ingredients and treatment methods, including the provision of a combination of (-) - cis-6-phenyl-5 - [4 - (2-pirrolidin-1-il-etoxi) - phenyl] - 5, 6, 7, 8-tetrahydronaphenyl-2-ol or an acceptable salt or hydrochlorofluorocarbon, as well as a specific aromatic inhibitor to patients in need. Carbamate formaldehyde1. Atamistano, anastrazol, fadrozol, finrozol, indiozol, vorozol, 4 - [n - (4-bromobenzene) - N - (4-cyanofluoromethane) amine] - 4h-1, 2, 4-trinitrozole or exemestan, or a salt acceptable for drugs. Item 6: a method for the treatment of senile osteoporosis, postmenopausal osteoporosis, osteoporosis, bone transplantation, breast cancer, ovarian cancer, obesity, osteoporosis, male osteoporosis, vulnerability, muscle injury or scabies, including the management of patients in need,1. Effective amount of (-) - cis-6-phenyl-5 - [4 - (2-pirrolidin-1-il-etoxi) - phenyl] - 5, 6, 7, 8-tetrahydronatelen-2-ol, or acceptable salt or recipe, and effective amount of aromatic inhibitor or acceptable salt or recipe;
展开▼
